Skip to main content
Premium Trial:

Request an Annual Quote

Jill Mesirov, Geoffrey Duyk, Joseph Catino, William Hancock, Brian Huber, Colin McKerlie

Premium

Jill Mesirov, CIO of the Whitehead/MIT Center for Genome Research, is one of six new members of the scientific advisory board of laboratory product and services company Charles River Laboratories of Wilmington, Mass. Other appointees include Geoffrey Duyk, CSO of Exelixis Pharmaceuticals; Joseph Catino, VP of Research of Bayer; William Hancock, chair in bioanalytical chemistry at the Barnett Institute at Northeastern University; Brian Huber, Vice President of the Biology Division, Drug Discovery, at GlaxoSmith-Kline; and Colin McKerlie, research scientist in the integrative biology program at the Hospital for Sick Children.

Filed under

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.